On September 9, 2009, the Registrant issued a press release announcing that it has secured two contracts for its Praziquantel tablets for the treatment and prevention of Schistosomiasis in livestock. A copy of the press release is attached as Exhibit 99.1, and the information in Exhibit 99.1 is incorporated herein by reference.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.